心臟結構植入物：創新和增長機會

Technology Innovations and Growth Opportunities in Structural Heart Implants

出版日期: 2022年12月19日 | 出版商:

Frost & Sullivan | 英文 64 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

本報告考察了全球心臟結構植入物市場，包括市場概況/背景、主要增長驅動因素/制約因素、關鍵植入物和設備的技術分析、行業分析和增長機會分析。

內容

戰略要務

增長問題
戰略要務 8 (TM)
三大戰略要務的影響
增長機會推動增長PipelineEngine (TM)
調查方法

增長機會分析

結構性心髒病 (SHD) 概述
最成熟的心臟瓣膜病介入技術：經皮二尖瓣成形術 (PTMV)
心臟結構植入物的分類
介入治療：主要針對有手術風險的患者
技術市場分析
增長動力
抑制增長的因素
分析範圍

經導管二尖瓣修復/置換 (TMVR) 植入物：技術分析

房間隔缺損 (Tc-ASD) 封堵器：技術分析

行業評估

支持 AI 的人工二尖瓣是 TMVR 的未來
3D 生物打印，仿生 ASD 封堵器
用於 MIS 的心臟結構植入物
需要在創新和法規之間取得平衡
TMVR/TMVr：專利數據庫分析
ASD 關閉裝置：專利數據庫分析
二尖瓣植入物和 ASD 封堵器新技術分析
人工智能在成長期心血管植入物中的應用

增長機會領域

增長機會：仿生或仿生心臟植入物可減少設備故障
增長機會：用於實時心臟參數檢索的微電子和支持 AI 的智能植入物
發展機會：聯合和內部開發使用心臟植入物的可視化技術

附錄

下一步

簡介目錄

Product Code: DA75

Biomaterials and Design Advances Improve the Efficacy and Safety of Heart Valves and Occluders

Structural heart diseases (SHD) encompass cardiac conditions that cause abnormal blood flow inside the heart's chambers, which can be wrong blood flow direction or blood stagnation. Structural abnormalities in the heart lead to impaired functioning rather than the heart's blood vessels. The cardiovascular implants industry has developed prosthetic valves and occluders to repair structural cardiac defects. This research study analyzes technological innovations in transcatheter mitral valve replacement/repair (TMVr/TMVR) implants and atrial septal defect (ASD) occluders. These implants are evolving to become more biomimetic and intelligent with artificial intelligence (AI)-enabled deployers.

The report also covers the following:

Industry trends
Active R&D areas
Emerging technologies
Notable stakeholders
Growth opportunities

Strategic Imperatives

Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Structural Heart Implants Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Research Methodology

Growth Opportunity Analysis

SHD Overview
Most Prevalent
Most Well-established Interventional Technique for Valvular Heart Disease: Percutaneous Mitral Valvuloplasty (PTMV)
PTMV is the Most Well-established Structural Interventional Technique (continued)
PTMV is the Most Well-established Structural Interventional Technique (continued)
Structural Heart Implants Segmentation
Interventional Treatment-Mainly for Patients at Surgical Risk
Market Analysis of Technologies
Market Analysis of Technologies (continued)
Market Analysis of Technologies (continued)
Market Analysis of Technologies (continued)
Market Analysis of Technologies (continued)
Growth Drivers
Growth Restraints
Scope of Analysis

Transcatheter Mitral Valves Repair/Replacement Implants-Technology Analysis

Preference to Mitral Valve Repair over Mitral Valve Replacement
Mitral Valve Material Analysis
Mitral Valve Material Analysis (continued)
Self-expanding Frame of the Valves Generally Comprises Nitinol
Most-adopted Design Intervention-Trileaflet Valve Comprising Pericardium in a Self-expanding Nitinol Frame
Most-adopted Design Intervention-Trileaflet Valve Comprising Pericardium in a Self-expanding Nitinol Frame (continued)
United States Has the Most Innovations in TMVr/TMVR

Transcatheter Atrial Septal Defect (Tc-ASD) Closure Devices-Technology Analysis

Tc-ASD can Treat ASD of Septum Secundum
ASD Material Analysis-Nitinol Wireframes Causing Erosion in Implanted Tc-ASD Devices
ASD Material Analysis-Nitinol Wireframes Causing Erosion in Implanted Tc-ASD Devices (continued)
Flexible Petal Design Ensures Less Friction Minimizing the Erosion
Gore Medical Tc-ASDs are FDA Approved and are the Most Successful
Tc-ASDs Geographical Analysis-United States Has the Most Innovations Dealing with Tc-ASDs

Industry Assessment

AI-enabled Prosthetic Mitral Valves as the Future of TMVR/TMVr
3D-bio-printed, Bio-inspired ASD Occluder is the Future
Structural Heart Implants for MIS
Need for Balancing Innovation and Regulation
Patent Database Analysis for TMVR/TMVr Industry
Patent Database Analysis for ASD Closure Devices
Emerging technology Analysis for Mitral Implants and ASD Occluders
Application of AI in Cardiovascular Implants in the Growth Phase

Growth Opportunity Universe

Growth Opportunity 1: Bio-inspired or Biomimetic Structural Heart Implants will Lead to Less Device Failure
Growth Opportunity 1: Bio-inspired or Biomimetic Structural Heart Implants will Lead to Less Device Failure (continued)
Growth Opportunity 2: Microelectronics and AI-enabled Smart Implants for Capturing Real-time Heart Parameters
Growth Opportunity 2: Microelectronics and AI-enabled Smart Implants for Capturing Real-time Heart Parameters (continued)
Growth Opportunity 3: Collaborative/In-house Development of Visualization Techniques with Cardiac Implants
Growth Opportunity 3: Collaborative/In-house Development of Visualization Techniques with Cardiac Implants (continued)